Pfizer (PFE): Orbimed Advisors LLC exited its position 3.85M shares
Orbimed Advisors LLC exited its position in Pfizer, per its Q2 2025 13F.
- 3.85M
- Prior-quarter shares · no longer reported
- Holdings as of
- Jun 30, 2025
- Filed
- Aug 14, 2025
What stands out in this filing
- The manager reported no shares in Q2 2025, after 3,850,200 in its Q1 2025 filing.
- 13 other tracked managers reported the same kind of change for Q2 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 3, 2025Congress · 2 peopleMembers of Congress: 2 sales
- Jul 10, 2025FDAFDA drug approval: Elrexfio
- Jul 10, 2025FDARecall: Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made…
- Jul 10, 2025FDARecall: Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made…
- Jul 16, 2025CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
- Jul 29, 2025FDARecall: Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851…
- Aug 4, 2025FDARecall: Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 04…
- Aug 4, 2025FDARecall: Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 004…
- Aug 4, 2025CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Aug 5, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
What came next
- Aug 25, 2025Layoff notice · BothellLayoff notice filed in WA: 100 employees
- Sep 11, 2025FDAFDA drug approval: Potassium Phosphates
- Sep 16, 2025FDAFDA drug approval: Ibrance
- Sep 16, 2025FDAFDA drug approval: Ibrance
- Oct 16, 2025FDAFDA drug approval: Xeljanz
- Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 26, 2025Government · Federal Register noticeForeign-Trade Zone (FTZ) 43; Authorization of Limited Production Activity; Pfizer, Inc.; (Pharmaceutical Intermediate Product); Kalamazoo, Michigan
- Dec 12, 2025Government · Federal Register noticePfizer Inc., U.S. Agent for King Pharmaceuticals LLC, et al.; Withdrawal of Approval of 20 Abbreviated New Drug Applications
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Pfizer
For Pfizer, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.
How this filing works
Explore the data
Common questions
What does this filing report about Pfizer (PFE) stock?
Orbimed Advisors LLC exited its position in Pfizer, per its Q2 2025 13F. Held the prior quarter, no longer listed per its Q2 2025 13F.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.
What stands out in this filing?
The manager reported no shares in Q2 2025, after 3,850,200 in its Q1 2025 filing. 13 other tracked managers reported the same kind of change for Q2 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Pfizer recently?
For Pfizer, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the PFE page.
Does this mean PFE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Pfizer
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordNov 12, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its PFE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
